Patents by Inventor Zeus Pendon

Zeus Pendon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and kits for omeprazole suspension
    Patent number: 12329752
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: June 17, 2025
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Zeus Pendon, Steven Dinh
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20240285527
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: January 3, 2024
    Publication date: August 29, 2024
    Inventors: Ken FALLIN, Zeus PENDON, Priya CAPILA, Neal MUNI
  • Compositions and kits for Omeprazole suspension
    Patent number: 12042539
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Grant
    Filed: March 30, 2023
    Date of Patent: July 23, 2024
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Zeus Pendon, Steven Dinh
  • Compositions and kits for omeprazole suspension
    Patent number: 11911473
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Grant
    Filed: March 30, 2023
    Date of Patent: February 27, 2024
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Zeus Pendon, Steven Dinh
  • Compositions and kits for omeprazole suspension
    Patent number: 11771686
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Grant
    Filed: August 20, 2020
    Date of Patent: October 3, 2023
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Zeus Pendon, Steven Dinh
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20230270862
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: March 30, 2023
    Publication date: August 31, 2023
    Inventors: Zeus PENDON, Steven DINH
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20230248830
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: March 30, 2023
    Publication date: August 10, 2023
    Inventors: Zeus PENDON, Steven Dinh
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20230233682
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: March 30, 2023
    Publication date: July 27, 2023
    Inventors: Zeus PENDON, Steven DINH
  • Compositions and kits for Omeprazole suspension
    Patent number: 11633478
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Grant
    Filed: January 14, 2022
    Date of Patent: April 25, 2023
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Zeus Pendon, Steven Dinh
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20220395479
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and /or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: August 16, 2022
    Publication date: December 15, 2022
    Inventors: Ken FALLIN, Zeus Pendon, Priya Capila, Neal Muni
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20220395480
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: August 16, 2022
    Publication date: December 15, 2022
    Inventors: Ken FALLIN, Zeus PENDON, Priya CAPILA, Neal MUNI
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20220370349
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: August 5, 2022
    Publication date: November 24, 2022
    Inventors: Ken FALLIN, Zeus PENDON, Priya CAPILA, Neal MUNI
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20220370414
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: August 5, 2022
    Publication date: November 24, 2022
    Inventors: Ken FALLIN, Zeus PENDON, Priya CAPILA
  • Suspensions and diluents for metronidazole and baclofen
    Patent number: 11446246
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Grant
    Filed: April 21, 2022
    Date of Patent: September 20, 2022
    Assignee: Azurity Pharmaceuticals, Inc.
    Inventors: Ken Fallin, Zeus Pendon, Priya Capila, Neal Muni
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20220257508
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: May 4, 2022
    Publication date: August 18, 2022
    Inventors: Ken FALLIN, Zeus PENDON, Priya CAPILA, Neal MUNI
  • SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
    Publication number: 20220241197
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Application
    Filed: April 21, 2022
    Publication date: August 4, 2022
    Inventors: Ken FALLIN, Zeus PENDON, Priya CAPILA, Neal MUNI
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20220211852
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: January 14, 2022
    Publication date: July 7, 2022
    Inventors: Zeus PENDON, Steven DINH
  • Suspensions and diluents for metronidazole and baclofen
    Patent number: 11324696
    Abstract: Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: May 10, 2022
    Assignee: AZURITY PHARMACEUTICALS, INC.
    Inventors: Ken Fallin, Zeus Pendon, Priya Capila, Neal Muni
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20220031683
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: August 31, 2021
    Publication date: February 3, 2022
    Inventors: Zeus PENDON, Steven Dinh
  • COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION
    Publication number: 20210346363
    Abstract: Disclosed herein are liquid diluents, formulations, and kits for preparing reconstituted suspensions of a proton pump inhibitor (e.g., omeprazole). The present disclosure also provides formulations for liquid diluents that do not have a tendency for gel formation following exposure to freeze-thaw cycles.
    Type: Application
    Filed: August 20, 2020
    Publication date: November 11, 2021
    Inventors: Zeus Pendon, Steven Dinh